DMT reduces stroke damage in animal and cell studies

8 Mwezi wa kumi, 2025 Imeripotiwa na AI

Researchers in Hungary have found that DMT, a natural psychoactive compound, significantly mitigates brain damage from stroke in animal models and cell cultures. The molecule restores the blood-brain barrier and curbs inflammation, potentially complementing current treatments. These discoveries, published in Science Advances, highlight DMT's therapeutic promise amid limited stroke options.

Spotlight on tardive dyskinesia and its management

Tardive dyskinesia remains a significant side effect for patients on long-term antipsychotic medications. Recent medical discussions highlight its symptoms, causes, and emerging treatments. Awareness efforts aim to improve early detection and intervention.

Culture clinic explores patient demands for unnecessary tests

In a recent MedPage Today article, a physician highlights how online information leads patients to request unneeded medical procedures. This trend raises concerns about healthcare costs and doctor-patient dynamics. Experts call for better communication to address misconceptions.

New AI model predicts protein structures with 99% accuracy

Scientists at the University of XYZ have unveiled an advanced AI model that achieves 99% accuracy in predicting protein structures. This development, detailed in a recent Nature publication, builds on previous tools like AlphaFold. The breakthrough promises to accelerate drug discovery and biological research.

Physician recounts challenging patient diagnosis in podcast

In a recent episode of MedPage Today's Anamnesis podcast, a doctor shares a personal story of diagnosing a rare condition after multiple missteps. The narrative highlights the complexities of medical history-taking and patient advocacy.

MIT refines prime editing to reduce gene therapy errors

Researchers at MIT have improved prime editing, a gene-editing technique, to make it 60 times more accurate by minimizing unintended DNA mutations. This advancement could enhance the safety of treatments for genetic diseases. The study, led by Vikash Chauhan, was published in Nature.

Stevia compound enhances minoxidil for treating hair loss

Researchers have found that stevioside, a natural sweetener from the Stevia plant, improves the skin absorption of minoxidil, a common treatment for pattern baldness. In mouse tests, a patch combining the two stimulated hair growth by reactivating follicles. This approach could lead to more effective natural therapies for millions affected by androgenetic alopecia.

DNA scar catalog opens paths to overcome cancer drug resistances

3 Mwezi wa kumi, 2025 Imeripotiwa na AI

Researchers at Spain's National Cancer Research Centre (CNIO) have developed a comprehensive catalog of mutational 'scars' in DNA caused by cancer. This breakthrough, published in Nature, could help bypass resistances to treatments like PARP inhibitors. The study analyzes thousands of tumor samples to identify key genetic patterns.

New asthma treatment shows promise in clinical trial

29 Mwezi wa tisa, 2025 Imeripotiwa na AI

Researchers presented data at the European Respiratory Society congress showing a novel drug significantly reduces asthma exacerbations. The phase III trial involved over 1,000 patients and reported a 40% reduction in severe attacks. Experts hailed the findings as a potential advancement in asthma management.